Company Search:
Advanced Search
Sponsored Links
Hvivo PLC Company Snapshot
Hvivo PLC operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hvivo PLC with three other pharmaceutical manufacturers in Europe: Lavipharm SA of Greece (2016 sales of 31.14 million Euro [US$36.33 million] ), Venture Life Group plc (£14.28 million [US$18.57 million] ), and Horizon Discovery Group PLC (£24.07 million [US$31.31 million] of which 53% was Services).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Hvivo PLC were £19.85 million (US$25.81 million). This is an increase of 157.2% versus 2015, when the company's sales were £7.72 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hvivo PLC
  Stock Performance Chart for Hvivo PLC
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 75.50p
(Figures in Pounds Sterling)
1 Week 2.0%   13 Weeks -16.1%  
4 Weeks -41.0%   52 Weeks -59.4%  
Hvivo PLC Key Data:
  Ticker: HVO Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 19,850,000
(Year Ending Jan 2017).
Employees: 255
  Currency: Pounds Sterling Market Cap: 58,987,628
  Fiscal Yr Ends: December Shares Outstanding: 78,129,308
  Share Type: Ordinary Closely Held Shares: 22,786,416
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.